(4S,5R)-2-(1,10-Phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole

Catalog No. :
ACHQVM159
CAS No. :
2828438-17-9
Molecular Formula :
C27H19N3O
Molecular Weight :
401.47

IUPAC Name:(4S,5R)-2-(1,10-phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole

(4S,5R)-2-(1,10-Phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$116.00Login to see priceIn stockInquiry
250mg98%$227.00Login to see priceIn stockInquiry
1g98%$652.00Login to see priceIn stockInquiry
5g98%$1889.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4S,5R)-2-(1,10-Phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole
IUPAC Name(4S,5R)-2-(1,10-phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole
Molecular FormulaC27H19N3O
Molecular Weight401.47
SMILESC12=C(C=CC=N2)C=CC3=C1N=C(C=C3)C4=N[C@H]([C@H](O4)C5=CC=CC=C5)C6=CC=CC=C6
InChI KeyMNKHFUNLOVIPJM-IZZNHLLZSA-N
Synonym1,10-Phenanthroline, 2-[(4S,5R)-4,5-dihydro-4,5-diphenyl-2-oxazolyl]-;(4S,5R)-2-(1,10-Phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole;2-[(4S,5R)-4,5-Dihydro-4,5-diphenyl-2-oxazolyl]-1,10-phenanthroline
CAS No.2828438-17-9
PubChem CID164890538

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACHQVM159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHQVM159 route product structure diagram
    ACHQVM1592828438-17-9 In Stock
Inquiry

2. ACHQVM159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHQVM159 route product structure diagram
    ACHQVM1592828438-17-9 In Stock
Inquiry

Comments (0)